Our Priorities

Global Oncology

Our Priorities

Nasreen Bhatti and Diana Basemera, UC-Fred Hutch Cancer Centre

Diana Basemera, histology technician, place a sliced tissue sample for dyeing at UCI-Fred Hutch Cancer Centre in Kampala, Uganda.

Photo by Jiro Ose for Fred Hutch

Reducing the burden of cancers around the world through improved diagnosis, better prevention strategies and optimized treatment plans.   

Nearly a quarter of the world’s cancers are caused by infectious diseases that are preventable or treatable, which include lymphoma from Epstein-Barr virus, sarcomas associated with HIV, cervical cancer from human papillomavirus and liver cancer from hepatitis B and C.

Non-Hodgkin lymphoma is among the rapidly increasing cancers in sub-Saharan Africa, particularly among HIV-infected individuals. For decades, Fred Hutch scientists have studied the biology, epidemiology and treatment of non-Hodgkin lymphoma as well as HIV/AIDS, including the role of the immune system in resisting HIV infection. We are leading one of the world’s largest studies to identify a safe and effective vaccine for HIV—the HIV Vaccine Trials Network, which involves 30 research sites on five continents.

Our Mission

To address these cancers we are focusing on the support of research, clinical care and training of cancer specialists, scientists and support staff in Uganda and other countries.  Our mission is to reduce the burden of cancers around the world through improved diagnosis, better prevention strategies and optimized treatment plans.

The cornerstone of our research and clinical work in global oncology is our decade-long collaboration with the Uganda Cancer Institute (UCI) in Kampala, Uganda. The UCI was, and still is, the only comprehensive cancer facility in a country of more than 37 million people, and it serves a five-country region with a total population of more than 100 million.
 

Goals

  • Improve diagnostic tools to promote and ensure early diagnosis and timely, accurate treatments.
  • Advance research to devise innovative strategies to prevent and treat infection-related cancers.
  • Enhance the quality and longevity of the lives of cancer patients by improving clinical care.
  • Create an enabling environment to address the rising cancer burden in low- and middle- income countries.